Bioventus Inc. Class A Common Stock BVS
$14.26
+2.66%
at last close
Financials (TTM)
- Revenue
- $581.85 million
- Net Income
- $61.48 million
- Net Margin
- 10.57%
- Return on Equity
- 22.16%
- Debt-to-Equity
- —
- P/E Ratio
- 18.52
- Price / Book
- 4.32
- Price / Sales
- 2.06
Over the trailing twelve months, Bioventus Inc. Class A Common Stock generated revenue of $581.85 million and net income of $61.48 million, a net margin of 10.57%.
At the last closing price of $14.26, BVS trades at 18.52 times trailing earnings and 2.06 times sales, with a market capitalization of $1.20 billion.
Key Stats
- Last Close
- $14.26
- Market Cap
- $1.20 billion
- 52-Week Range
- $5.81 – $15.89
- Average Volume
- 818K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.